Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer
Pulmonary Symptoms Measured by the National Institutes of Health Lung Score Predict Overall Survival, Nonrelapse Mortality, and Patient-Reported Outcomes In Chronic Graft-Versus-Host Disease - Biology of Blood and Marrow Transplantation
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
Overall Survival Results with KISQALI® (ribociclib)
A joint international consensus statement for measuring quality of survival for patients with childhood cancer | Nature Medicine
JCI Insight - A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia
JCI Insight - A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia
Trial Outcome Measures | Download Table
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
27 Survival analysis | The Epidemiologist R Handbook
Impact of social disparities on 10 year survival rates in paediatric cancers: a cohort study - The Lancet Regional Health – Americas
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Measures of Cancer Survival
Survival Analysis
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and ...
Overall Survival Results with KISQALI® (ribociclib)
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed | Nature Reviews Clinical Oncology
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis - European Urology Focus
Figure 1, Outcome Measures Framework - Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned - NCBI Bookshelf
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe
Progression-Free Survival: Meaningful or Simply Measurable? | Journal of Clinical Oncology
Trial Outcome Measures | Download Table
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study - ScienceDirect
